11/6/2016

Testosterone Cypionate Injection

Products Affected - Description

- Testosterone cypionate intramuscular injection, Actavis, 200 mg/mL, 10 mL vial, 1 count, NDC 00591-3223-79
- Testosterone cypionate intramuscular injection, Sun Pharma, 100 mg/mL, 10 mL vial, 1 count, NDC 62756-0017-40
- Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 1 mL vial, 1 count, NDC 62756-0015-40
- Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 10 mL vial, 1 count, NDC 62756-0016-40

Reason for the Shortage

- Actavis discontinued testosterone cypionate injection in 2015.
- Paddock had testosterone on shortage due to increased demand and shipping delays from their contract manufacturer.
- West-Ward had testosterone cypionate on shortage due to manufacturing delays.
- Sandoz discontinued testosterone cypionate 200 mg/mL 1 mL and 10 mL vials in September 2011. Sandoz discontinued final presentation in first half of 2012.
- Sun Pharma will not provide availability information.

Available Products

- Depo-Testosterone intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, NDC 00009-0347-02
- Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00009-0417-01
- Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00009-0417-02
- Testosterone cypionate intramuscular injection, Paddock, 200 mg/mL, 1 mL vial, 1 count, NDC 00574-0820-01
- Testosterone cypionate intramuscular injection, Paddock, 200 mg/mL, 10 mL vial, 1 count, NDC 00574-0827-10
- Testosterone cypionate intramuscular injection, Paddock, 200 mg/mL, 10 mL vial, 1 count, NDC 00574-0820-10
- Testosterone cypionate intramuscular injection, West-Ward, 200 mg/mL, 10 mL vial, 1 count, NDC 00143-9726-01

Estimated Resupply Dates

- Sun Pharma will not provide any availability information at this time.
- All other marketed presentations are available.

Updated

Updated November 6, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 8, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.